...Intermountain, New Enterprise Associates, and Founder Collective. Their repositioning into ‘between-visit care model’ expanding from diabetes into obesity, hypertension, and MSK patients has met with success. With 2,000+ customers and over 679,000 total members enrolled in one or more programs, their 2024 revenue grew 38% from $122.8 million in 2023 to $169.8 million in 2025 , with Q1 2025 by 57% to $55.0 million from Q1 2024’s $35.1 million. Their prospectus revealed that they are closely tied to investor Cigna, with one health plan or PBM accounting for 31% of revenue, then a second health plan or PBM accounted for... Continue Reading
Search Results for anthem cigna
Short takes: Midi Health’s longevity care for women covered by (some) insurance, NZ government 24/7 telehealth scored by GPs, Auxira tele-cardiology follow-up launches
...shifting to be more than menopause and about more of the total women’s longevity picture. Axios Unfortunately, the drawbacks are many to many most interested. There’s no genetic testing. And while some commercial insurers like UnitedHealth, Cigna, HealthNet, and some Blue plans participate, the big omission is Medicare and Medicare-related plans, such as Medicare supplements and Medicare Advantage. The third is marketing that excludes older women. This Editor hates to be Debbie Downer as Midi is trying hard to provide more care plus a continuity of care to women traditionally ignored who are most interested in health and longevity–and believe... Continue Reading
Should free-falling UnitedHealth Group be broken up? Or break itself up to survive, before it becomes another GE? (updated)
Breaking up is hard to do. But should be done if UHG wants to survive and thrive. Our proposition: UnitedHealth Group has become a victim of its own giantism, conflicts, and focus on financials–and its failure will drag down healthcare. How big? By far, it is the largest US health insurance company based on 2023 enrollments with a 15% market share, 29 million members, and $371.6 billion in revenue. It leads by far Elevance Health (formerly Anthem, 12%), CVS Health/Aetna (12%), Cigna (11%) and Health Care Service Corporation (7%). A more realistic picture of its size is that it is... Continue Reading
News roundup: Hinge Health public @$32/share, lower valuation. Is WeightWatchers game over? Calibrate replaces CEO, new prez for Oak Street, NMC gets ‘Smarter’ rolling up 3 portfolio companies, another splash of investor ‘cold water’
...those who promise a lot less effort, even with cost and side effects that are significant. Now it costs even less. Cigna’s Evernorth announced yesterday that its PBM Express Scripts now will cap monthly out-of-pocket costs of Novo Nordisk’s Wegovy and Lilly’s Zepbound at $200/month, saving an estimated $3,600 annually versus typical DTC discount programs. FierceHealthcare Can WW buy enough time to solve their market problem? Based on prior marketing experience, it’s not likely even if WW completely reinvents itself. Even among the weight loss teleprescribers, all is not keen and peachy. Calibrate changed out its second CEO in just... Continue Reading
News roundup: Omada Health files for IPO, UPMC-Redesign partner on chronic pain management, OK and PA AGs warn 23andMe users to delete data, Verily to build Parkinson’s dataset, what payers paid for exec security
...the company plane; $7,713 for the use of a company car and driver; and $82,603 on home security. Personal travel expenses using company resources must be reimbursed over $250,000 (!). Previous CEO Karen Lynch racked up expenses of $242,051 on personal aircraft use; $95,199 on the use of a company car and driver; and $44,645 on personal protection. Security totaling $56,610 was extended to her for six months after she was replaced by David Joyner. Cigna’s CEO David Cordani is required to use the company aircraft for business and personal travel. The latter totaled $231,008 in 2024. Spending for executive... Continue Reading
Midweek roundup: Transcarent closes Accolade; Walgreens beats Street; New Mountain Capital’s Office Ally buy-in; Neuralink Blindsight human trial coming up; PM Keir Starmer touts NHS data research; FTC’s PBM litigation break
...The UK government and the Wellcome Trust will invest up to £600 million. This is part of the government’s Plan for Change to set up a modern industrial strategy, unlocking the potential of the Oxford‑Cambridge growth corridor, and “pro-growth measures to build a strong, resilient economy with more well-paid jobs”. Gov.uk release A longish break for the major pharmacy benefit management (PBM) companies. The Federal Trade Commission (FTC) announced that it was staying its insulin pricing litigation against the three major PBMs: Caremark (CVS), Express Scripts (Cigna), and Optum Rx (UnitedHealth Group). The long-running action initiated last year by the... Continue Reading
News roundup: PSI awarded $156M contract for VA EHR testing; $50M for Fay nutrition; General Catalyst’s wealth management expansion; UniDoc’s HealthCube debuts in Ukraine
...2024 to $75 million. The fresh funding will pay for growth and network expansion. They are claiming a valuation of $500 million. Fay at present has a network covering most states of 2,300 registered dietitians (RDs) that integrate through Fay’s platform with major payers including United Healthcare, Aetna CVS Health, Blue Cross, Anthem, Cigna, Optum, and Humana, plus large employers such as Amazon, Microsoft, and Pepsi. The RDs provide personalized, in-person or virtual nutrition and lifestyle counseling to members or employees at little to no cost, while the platform automates processes such as insurance claims, scheduling, and patient follow-ups for... Continue Reading
A year’s end newsletter to our Readers: a few wishes for Under the Tree, a few Quirky Predictions for 2025
...7s and 11s (UK=administration) along the way. There will be more layoffs. Funding rounds for both healthcare and digital health will be moderate. Down rounds that reduce valuation will still be with us. Investors will push for more control–witness what is happening at Walgreens and CVS, and what happened at Centene. There will be more big changes at Walgreens, CVS, Elevance, Centene, Cigna, and many others considered mainstays of healthcare–and don’t rule out Amazon and Walmart. But by the end of year, barring a Bird Flu Pandemic, space aliens landing from the Plague of Drones in US and international skies,... Continue Reading
VillageMD’s co-founder/CEO resigns as Walgreens continues the brush-off after billions in losses
...locations to Walgreens’ stores proved to be both expensive and difficult. These factors and others sank Roz Brewer’s CEO-dom, the share price, and the vision of Mr. Barry’s and VillageMD’s founders and physicians. The last dated back to 2013 and built into a network of hundreds of freestanding primary care clinics in value-based care. Many of the 140+ closures starting early this year were not only of expansions, but also of long-standing VillageMD offices, including in its core market of Chicago metro. Earlier this year, Cigna wrote off most of its $2.5 billion investment, throwing its Q1 into the red... Continue Reading
M&A action news: Astrana Health buys up Prospect Health for $745M after Centene MSO unit buy, Veradigm nears $1B+ sale, Sword Health lays off 17% of clinicians prepping for IPO using AI instead, Cigna is not buying Humana–really! truly!
...benefit management business under Express Scripts, TTA 1 Oct.) From the Cigna release: “Additionally, in light of recent and persistent speculation, The Cigna Group expects to communicate that the company is not pursuing a combination with Humana Inc. The Cigna Group remains committed to its established M&A criteria and would only consider acquisitions that are strategically aligned, financially attractive, and have a high probability to close.” You wonder who’s been fluffing along this rumor to this extent, and why. The tale of the tape? Cigna shares are up 4.5% in the past five days, while Humana’s are down 4%. FierceHealthcare... Continue Reading
Most Recent Comments